These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28007970)

  • 1. Dual effects of fructose on ChREBP and FoxO1/3α are responsible for AldoB up-regulation and vascular remodelling.
    Cao W; Chang T; Li XQ; Wang R; Wu L
    Clin Sci (Lond); 2017 Feb; 131(4):309-325. PubMed ID: 28007970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of aldolase B and overproduction of methylglyoxal in vascular tissues from rats with metabolic syndrome.
    Liu J; Wang R; Desai K; Wu L
    Cardiovasc Res; 2011 Dec; 92(3):494-503. PubMed ID: 21890532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency.
    Buziau AM; Oosterveer MH; Wouters K; Bos T; Tolan DR; Agius L; Ford BE; Cassiman D; Stehouwer CDA; Schalkwijk CG; Brouwers MCGJ
    Mol Metab; 2024 Sep; 87():101984. PubMed ID: 38972375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
    Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
    J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome.
    Oh AR; Sohn S; Lee J; Park JM; Nam KT; Hahm KB; Kim YB; Lee HJ; Cha JY
    Metabolism; 2018 Aug; 85():286-297. PubMed ID: 29669261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
    Tao QF; Yuan SX; Yang F; Yang S; Yang Y; Yuan JH; Wang ZG; Xu QG; Lin KY; Cai J; Yu J; Huang WL; Teng XL; Zhou CC; Wang F; Sun SH; Zhou WP
    Mol Cancer; 2015 Sep; 14():170. PubMed ID: 26376879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
    Liu G; Wang N; Zhang C; Li M; He X; Yin C; Tu Q; Shen X; Zhang L; Lv J; Wang Y; Jiang H; Chen S; Li N; Tao Y; Yin H
    Hepatology; 2021 Dec; 74(6):3037-3055. PubMed ID: 34292642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation.
    Ido-Kitamura Y; Sasaki T; Kobayashi M; Kim HJ; Lee YS; Kikuchi O; Yokota-Hashimoto H; Iizuka K; Accili D; Kitamura T
    PLoS One; 2012; 7(10):e47231. PubMed ID: 23056614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of aldolase A and methylglyoxal production in adipocytes.
    Liu J; Desai K; Wang R; Wu L
    Br J Pharmacol; 2013 Apr; 168(7):1639-46. PubMed ID: 23126339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of FOXO1/3 promotes vascular calcification.
    Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats.
    Dhar I; Dhar A; Wu L; Desai KM
    PLoS One; 2013; 8(9):e74212. PubMed ID: 24040205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of SENCR promotes smooth muscle cells proliferation and migration in db/db mice through up-regulation of FoxO1 and TRPC6.
    Zou ZQ; Xu J; Li L; Han YS
    Biomed Pharmacother; 2015 Aug; 74():35-41. PubMed ID: 26349960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
    Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
    Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex.
    He X; Li M; Yu H; Liu G; Wang N; Yin C; Tu Q; Narla G; Tao Y; Cheng S; Yin H
    PLoS Biol; 2020 Dec; 18(12):e3000803. PubMed ID: 33275593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.
    Zhang D; Tong X; VanDommelen K; Gupta N; Stamper K; Brady GF; Meng Z; Lin J; Rui L; Omary MB; Yin L
    J Clin Invest; 2017 Jun; 127(7):2855-2867. PubMed ID: 28628040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells.
    Li X; Kover KL; Heruth DP; Watkins DJ; Moore WV; Jackson K; Zang M; Clements MA; Yan Y
    Mol Endocrinol; 2015 Aug; 29(8):1184-94. PubMed ID: 26147751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
    Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
    Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats.
    Wang X; Jia X; Chang T; Desai K; Wu L
    J Hypertens; 2008 Apr; 26(4):765-72. PubMed ID: 18327087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension.
    Hernanz R; Martínez-Revelles S; Palacios R; Martín A; Cachofeiro V; Aguado A; García-Redondo L; Barrús MT; de Batista PR; Briones AM; Salaices M; Alonso MJ
    Br J Pharmacol; 2015 Jun; 172(12):3159-76. PubMed ID: 25712370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.